Foundation Fighting Blindness

VISIONS 2026: United in Vision The United in Vision 2026 conference unites two prestigious events—the Foundation Fighting Blindness VISIONS conference and the Retinal International World Congress—into one extraordinary global gathering. Scheduled from Wednesday, June 10, to Saturday, June 13, 2026, at the Omni Fort Worth Hotel and Fort Worth Convention Center in Fort Worth, Texas.

Save the date! United in Vision 2026 combines the VISIONS Conference & Retina International World Congress. Join us June 10-13, 2026, in Fort Worth, TX, for collaboration, innovation & hope. 💙

Learn more: www.FightingBlindness.org/VISIONS2026

01.04.2025 18:04 — 👍 3    🔁 1    💬 0    📌 2

Promotional image for the February 2025 issue of ARVO's Investigative Ophthalmology & Visual Science (IOVS) journal, featuring a colorful microscopic image of cells on the cover. The text highlights the availability of new content and includes the journal's website url: iovs.arvojournals.org.

This month in @arvoinfo.bsky.social IOVS journal, review the largest assessment across multiple continents of genetic causality in the patient population of #InheritedRetinalDiseases: bit.ly/42Jej2V
@fightblindness.bsky.social #ARVOjournals #OpenAccess

05.02.2025 21:40 — 👍 1    🔁 2    💬 0    📌 0

The image is a screenshot of a zoom session with a powerpoint slide on the left and participants on the right hand side.

The RI Education Hub continued today with two excellent presentations on Patient Registries from Russell Wheeler and Todd Durham @fightblindness.bsky.social. Thanks to our speakers and participants for their participation and engagement #IRD #Genetics #GeneticTesting #Registries #ClinicalTrials

07.02.2025 13:05 — 👍 2    🔁 2    💬 0    📌 0

Age-related macular degeneration (AMD) affects millions, causing central vision loss. This simulation offers a glimpse into what those living with AMD may experience.

06.02.2025 19:24 — 👍 2    🔁 0    💬 0    📌 0

Eva Lou Schroeder Watson's Enduring Legacy Eva Watson's life was marked by her dedication to advancing medical research for blinding diseases, and her generous bequest to the Foundation Fighting Blindness ensures her advocacy will endure. Her ...

Meet Eva. Eva Watson’s life was marked by her dedication to advancing research for blinding diseases. Her story highlights the profound impact of her contributions to driving treatments and cures for blinding diseases.

Read Eva's full Beacon Story on our website at: bit.ly/4gawEZW

29.01.2025 21:26 — 👍 0    🔁 0    💬 0    📌 0

Nacuity Pharmaceuticals Granted U.S. FDA Fast Track Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa

Nacuity Pharmaceuticals granted U.S. FDA fast track designation for NPI-001 (N-acetylcysteine amide) tablets for the treatment of retinitis pigmentosa.

Read more on our website at: bit.ly/3E3pfhv

22.01.2025 20:01 — 👍 0    🔁 0    💬 0    📌 0

Retinal Therapeutics Innovation Summit 2025 {{MetaTags.description}}

Mark your calendars! The Retinal Therapeutics Innovation Summit 2025 is happening on May 2 in Salt Lake City, UT!

Hear from top experts, discuss emerging therapies, and strategize solutions to accelerate clinical applications.

Seating is limited to 500—reserve now! bit.ly/4hhIOBa

17.01.2025 19:43 — 👍 6    🔁 5    💬 0    📌 0

VisionWalk VisionWalk Home Page

Spring into action, VisionWalkers!

Register your team for your local Spring #VisionWalk by February 1st and you’ll be entered to win an unforgettable prize: lunch with our CEO, Jason Menzo!

Sign up today at www.VisionWalk.org!

16.01.2025 18:32 — 👍 1    🔁 0    💬 0    📌 0

'Finding your community': NJ blind hockey team looking for more players Josh Schneider lost 98% of his eyesight and retired from teaching at age 37. Then he found blind hockey with Jersey Blind.

Today, we're happy to share the incredible journey of blind hockey players in New Jersey, as highlighted in the NJ Herald. This inspiring article features athletes breaking barriers and redefining what’s possible on the rink.

Read the full article at: bit.ly/3DYu63K

15.01.2025 19:28 — 👍 0    🔁 1    💬 0    📌 0